Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
Nasdaq proposes stricter listing rules to enhance investor protection and market integrity, including higher minimum public float and capital raise requirements for Chinese firms.
Porsche AG, a luxury sports car maker, is being removed from Germany's DAX index due to a significant decline in its share price and profitability amid global trade tensions and sector-specific challenges.
Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
Nasdaq proposes stricter listing rules to enhance investor protection and market integrity, including higher minimum public float and capital raise requirements for Chinese firms.
Porsche AG, a luxury sports car maker, is being removed from Germany's DAX index due to a significant decline in its share price and profitability amid global trade tensions and sector-specific challenges.